This presentation, sponsored by Pierrel Pharma, a global leader in quality dental anesthetics, will introduce you to Orabloc®, an aseptically produced articaine anesthetic that clearly differentiates itself from all other local anesthetics on the market. Successfully used by clinicians for years throughout Europe, Orabloc® is now approved by the FDA for use in the U.S.

Orabloc® delivers a rapid onset time of one to nine minutes and a reliable duration of up to one hour. It has a 33% longer shelf life, less epinephrine overages than anesthetic made with a terminal sterilization process, and requires less volume than lidocaine anesthetics.   ( disclaimer )